Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseBone MarrowTransplantation ConditioningBone Marrow CellsHematologic NeoplasmsTransplantation, AutologousWhole-Body IrradiationTransplantation ChimeraStem CellsTissue DonorsLeukemiaBusulfanStem Cell TransplantationGraft vs Leukemia EffectGraft SurvivalHistocompatibilityHematopoiesisHistocompatibility TestingAnemia, AplasticTreatment OutcomeRecurrenceGraft vs Tumor EffectLeukemia, Myeloid, AcuteMice, Inbred C57BLBone and BonesTransplantation, IsogeneicHematologic DiseasesRetrospective StudiesChimerismMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaMyeloablative AgonistsImmunosuppressive AgentsTime FactorsCyclophosphamideHepatic Veno-Occlusive DiseaseCell DifferentiationRemission InductionLymphocyte TransfusionPeripheral Blood Stem Cell TransplantationHLA AntigensAcute DiseaseT-LymphocytesFlow CytometryCytomegalovirus InfectionsTransplantation ImmunologyCombined Modality TherapyColony-Forming Units AssayAntigens, CD34Liver TransplantationAllograftsLymphocyte DepletionHematopoietic Stem Cell MobilizationCord Blood Stem Cell TransplantationVidarabineSurvival AnalysisBone Marrow PurgingCell LineageRadiation ChimeraSevere Combined ImmunodeficiencySurvival RateLeukemia, MyeloidSiblingsImmunosuppressionCells, CulturedGraft RejectionOpportunistic InfectionsCystitisBone Marrow DiseasesFollow-Up StudiesStem Cell NicheMinor Histocompatibility AntigensDisease-Free SurvivalFetal BloodAdult Stem CellsKidney TransplantationNeoplasm, ResidualEmbryonic Stem CellsCell SeparationLymphoproliferative DisordersLeukemic InfiltrationCyclosporineAntilymphocyte SerumCytomegalovirusFatal OutcomeMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorGraft vs Host ReactionThymus GlandMice, Inbred BALB CImmunophenotypingImmunocompromised HostChimeraBone Marrow Examination